Potential for inhalation exposure to engineered nanoparticles from nanotechnology-based cosmetic powders

Environmental Health Perspectives

Volumn 120, Issue 6, 2012, Pages 885-892

  Nazarenko, Yevgen ^a   Zhen, Huajun ^a   Han, Taewon ^a   Lioy, Paul J ^b,c   Mainelis, Gediminas ^a,c  

^a Rutgers University   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Consumer products; Cosmetics; Emerging contaminants; Inhalation exposure; Nanoaerosol; Nanomaterials; Nanoparticles; Personal exposure

Indexed keywords

ALUMINUM HYDROXIDE; CALCIUM CARBONATE; COSMETIC; IRON OXIDE; KAOLIN; NANOPARTICLE; SILICON DIOXIDE; TALC; TITANIUM DIOXIDE; ZINC OXIDE;

ADULT; AIRBORNE PARTICLE; AIRWAY OBSTRUCTION; ARTICLE; CONTROLLED STUDY; EXPOSURE; FEMALE; HEALTH HAZARD; HUMAN; HUMAN EXPERIMENT; LASER DIFFRACTION; LUNG ALVEOLUS CELL; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; REFRACTION INDEX; RESPIRATORY TRACT DISEASE; SPECTROSCOPY; TRACHEOBRONCHIAL TREE; TRANSMISSION ELECTRON MICROSCOPY;

COSMETICS; HUMANS; INHALATION EXPOSURE; LASERS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POWDERS; SPECTRUM ANALYSIS;

EID: 84862014319     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104350     Document Type: Article

References (58)

1. Baroli B. 2009. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci 99(1):21-50.
2. Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, López-QuintelaMA. 2007. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 127:1701-1712.
3. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, et al. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77:347-357.
4. Bradford A, Handy RD, Readman JW, Atfield A, Mühling M. 2009. Impact of silver nanoparticle contamination on the genetic diversity of natural bacterial assemblages in estuarine sediments. Environ Sci Technol 43(12):4530-4536.
5. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175(3):191-199.
6. Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, et al. 2009. Nanoparticle dermal absorption and toxicity: a review of the literature. Int Arch Occup Environ Health 82:1043-1055.
7. Drobne D. 2007. Nanotoxicology for safe and sustainable nanotechnology. Arh Hig Rada Toksikol 58(4):471-478.
8. Duffin R, Tran L, Brown D, Stone V, Donaldson K. 2007. Proinflammogenic effects of low-toxicity and metal nanoparticles invivo and invitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19(10):849-856.
9. Frater L, Stokes E, Lee R, Oriola T. 2006. An Overviewof the Framework of Current Regulation Affecting the Development and Marketing of Nanomaterials. Cardiff, UK:Cardiff University.
10. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, KreylingW, Schulz H, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555-1560.
11. Gillespie JB, Lindberg JD. 1992. Ultraviolet and visible imaginary refractive index of strongly absorbing atmospheric particulate matter. Appl Opt 31(12):2112-2115.
12. Gwinn MR, Vallyathan V. 2006. Nanoparticles: health effects-pros and cons. Environ Health Perspect 114:1818-1825.
13. Hagendorfer H, Lorenz C, Kaegi R, Sinnet B, Gehrig R, Goetz NV, et al. 2010. Size-fractionated characterization and quantification of nanoparticle release rates from a consumer spray product containing engineered nanoparticles. J Nanopart Res 12(7):2481-2494.
14. Hansen SF, Michelson ES, Kamper A, Borling P, Stuer-Lauridsen F, Baun A. 2008. Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 17:438-447.
15. Hinds WC. 1999. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. 2nd ed. New York:John Wiley & Sons.
16. Holgate ST. 2010. Exposure, uptake, distribution and toxicity of nanomaterials in humans. J Biomed Nanotechnol 6(1):1-19.
17. International Commission on Radiological Protection. 1994. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP 24(1-3):1-482.
18. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40(4):328-346.
19. Jones R. 2002. Successful particle size analysis of dry powders. GIT Lab J 6(2):46-48.
20. Keenan CR, Goth-Goldstein R, Lucas D, Sedlak DL. 2009. Oxidative stress induced by zero-valent iron nanoparticles and Fe(II) in human bronchial epithelial cells. Environ Sci Technol 43(12):4555-4560.
21. Kessler R. 2011. Engineered nanoparticles in consumer products: understanding a new ingredient. Environ Health Perspect 119:A120-A125.
22. Larese FF, D'Agostin F, Crosera M, Adami G, Renzi N, BovenziM, et al. 2009. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255(1-2):33-37.
23. Li W-I, Perzl M, Heyder J, Langer R, Brain JD, Englmeier K-H, et al. 1996. Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities. J Aerosol Sci 27(8):1269-1286.
24. Lioy PJ. 2010. Exposure science: a view of the past and major milestones for the future. Environ Health Perspect 118:1081-1090.
25. Lioy PJ, Nazarenko Y, Han TW, Lioy MJ, Mainelis G. 2010. Nanotechnology and exposure science-what is needed to fill the research and data gaps for consumer products. Int J Occup Environ Health 16(4):376-385.
26. Lioy PJ, Pellizzari E, Prezant D. 2006. The World Trade Center aftermath and its effects on health: understanding and learning through human-exposure science. Environ Sci Technol 40(22):6876-6885.
27. Malvern Instruments Ltd. 2011. Laser Diffraction Particle Sizing. Available: http://www.malvern.com/LabEng/technology/laser_diffraction/particle_sizing.htm [accessed 11 January 2011].
28. Marambio-Jones C, Hoek E. 2010. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12(5):1531-1551.
29. Matyi RJ, Schwartz LH, Butt JB. 1987. Particle size, particle size distribution, and related measurements of supported metal catalysts. Catalysis Rev 29(1):41-99.
30. Maynard AD. 2007. Nanotechnology: the next big thing, or much ado about nothing. Ann Occup Hyg 51(1):1-12.
31. Maynard AD, Aitken RJ. 2007. Assessing exposure to airborne nanomaterials: current abilities and future requirements. Nanotoxicology 1(1):26-41.
32. Maynard AD, Aitken RJ, Butz T, Colvin C, Donaldson K, Oberdörster G, et al. 2006. Safe handling of nanotechnology. Nature 444:267-269.
33. Michelson ES. 2008. Globalization at the nano frontier: the future of nanotechnology policy in the United States, China, and India. Technol Society 30:405-410.
34. Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, et al. 2007. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 64:609-615.
35. Nazarenko Y, Han TW, Lioy PJ, Mainelis G. 2011. Potential for exposure to engineered nanoparticles from nano-technology-based consumer spray products. J Expo Sci Environ Epidemiol 21:515-528.
36. Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
37. Nowack B, Bucheli TD. 2007. Occurrence, behavior and effects of nanoparticles in the environment. Environ Pollut 150(1):5-22.
38. Oberdörster G, Maynard A, Donaldson K, Castranova V, FitzpatrickJ, Ausman K, et al. 2005a. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8; doi:10.1186/1743-8977-2-8 [Online 6 October 2005].
39. Oberdörster G, Oberdörster E, Oberdörster J. 2005b. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
40. Ostrowski AD, Martin T, Conti J, Hurt I, Harthorn BH. 2009. Nanotoxicology: characterizing the scientific literature, 2000-2007. J Nanoparticle Res 11:251-257.
41. Paull J, Lyons K. 2008. Nanotechnology: the next challenge for organics. J Organic Syst 3(1):3-22.
42. Riediker M. 2009. Chances and risks of nanomaterials for health and environment. In: Lecture Notes of the Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering, Vol 20 (Schmid A, GoelS, Wang W, Beiu V, Carrara S, eds). Heidelberg:Springer, 128-133. Available: http://www.scribd.com/kentme/d/28491514-Lecture-Notes-of-the-Institute-for-Computer [accessed 11 January 2011].
43. Savolainen K, Alenius H, Norppa H, Pylkkänen L, Tuomi T, Kasper G. 2010. Risk assessment of engineered nanomaterials and nanotechnologies-a review. Toxicology 269(2-3):92-104.
44. Sayes CM, Reed KL, Glover KP, Swain KA, Ostraat ML, DonnerEM, et al. 2010. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles. Inhal Toxicol 22(4):348-354.
45. Schilling K, Bradford B, Castelli D, Dufour E, Nash JF, Pape W, et al. 2010. Human safety review of "nano" titanium dioxide and zinc oxide. Photochem Photobiol Sci 9(4):495-509.
46. Segal SH. 2004. Environmental regulation of nanotechnology: avoiding big mistakes for small machines. Nanotechnol Law Bus 1(3):290-304.
47. Senzui M, Tamura T, Miura K, Ikarashi Y, Watanabe Y, Fujii M. 2010. Study on penetration of titanium dioxide (TiO2) nanoparticles into intact and damaged skin in vitro. J Toxicol Sci 35(1):107-113.
48. Shimada M, Wang W-N, Okuyama K, Myojo T, Oyabu T, Morimoto Y, et al. 2009. Development and evaluation of an aerosol generation and supplying system for inhalation experiments of manufactured nanoparticles. Environ Sci Technol 43(14):5529-5534.
49. Shrader-Frechette K. 2007. Nanotoxicology and ethical conditions for informed consent. Nanoethics 1:47-56.
50. Som C, Berges M, Chaudhry Q, Dusinska M, Fernandes T, OlsenS, et al. 2010. The importance of life cycle concepts for the development of safe nanoproducts. Toxicology 269:160-169.
51. Thomas T, Bahadori T, Savage N, Thomas K. 2009. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(4):426-433.
52. U.S. Environmental Protection Agency. 1997. Exposure Factors Handbook. EPA/600/P-95/002Fa, b, c. Washington, DC:U.S. Environmental Protection Agency.
53. Van Calster G. 2006. Regulating nanotechnology in the European Union. Nanotechnol Law Bus 3(3):359-374.
54. Wardak A, Gorman ME, Swami N, Deshpande S. 2008. Identification of risks in the life cycle of nanotechnology-based products. J Ind Ecol 12(3):435-448.
55. Warheit DB, Borm PJA, Hennes C, Lademann J. 2007. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal Toxicol 19:631-643.
56. Warheit DB, Brock WJ, Lee KP, Webb TR, Reed KL. 2005. Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: impact of surface treatments on particle toxicity. Toxicol Sci 88(2):514-524.
57. Woodrow Wilson International Center for Scholars. 2011a. The Project on Emerging Nanotechnologies: Consumer Products: An Inventory of Nanotechnology-Based Consumer Products Currently on the Market. Available: http://www.nanotechproject.org/inventories/consumer/ [accessed 7 January 2011].
58. Woodrow Wilson International Center for Scholars. 2011b. The Project on Emerging Nanotechnologies: News. Available: http://www.nanotechproject.org/ [accessed 26 May 2011].